Center for Reproductive Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, Jiangsu, China.
Center for Experimental Animal, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Hum Reprod. 2021 Jan 1;36(1):145-159. doi: 10.1093/humrep/deaa261.
What are the localization, characteristics and potential for tissue regeneration of two perivascular stem cells, namely CD34+ adventitial cells and CD146+ pericytes, in human endometrium?
Human endometrial CD34+ adventitial cells (located in the outermost layer of blood vessels and mainly in the basal layer) and CD146+ pericytes showed mesenchymal stem cell (MSC) phenotypes in in vitro culture, but presented limited potential to regenerate endometrium.
Periodic endometrial regeneration is considered to be maintained by MSCs. Blood vessel wall, regarded as stem cell niche, harbors a large reserve of progenitor cells that may be integral to the origin of MSCs. However, a lack of validated markers has hampered the isolation of putative endometrial MSCs. Currently, CD146+ pericytes and Sushi Domain Containing 2 (SUSD2) positive cells have been identified in the endometrial perivascular region as sharing MSCs characteristics.
STUDY DESIGN, SIZE, DURATION: The locations of adventitial cells and pericytes in the human endometrium were identified by immunofluorescence staining (n = 4). After CD34+CD146-CD45-CD56-CD144- adventitial cells and CD146+CD34-CD45-CD56-CD144- pericytes were isolated from the endometrium of normal women (n = 6) by fluorescence-activated cell sorting, their characteristics were investigated in culture. Adventitial cells and pericytes were induced to differentiate, respectively, into vascular endothelial-like cells or endometrial stromal-like cells in vitro, with their potential explored by in vivo xenotransplantation (n = 2 in each group) and eutopic transplantation (n = 2 in each group).
PARTICIPANTS/MATERIALS, SETTING, METHODS: CD34+ adventitial cells and CD146+ pericytes were cultured in the inducing medium to differentiate into endothelial-like cells in vitro, and then analyzed for CD31, von Willebrand factor immunofluorescent staining and tube formation. They were also cultured to differentiate into endometrial stromal cells in vitro, with the expression of vimentin and CD13 being detected by western blot before and after induction, and the expression of prolactin and insulin-like growth factor-binding protein 1 being determined as well. Single dispersed CD34+ adventitial cells and CD146+ pericytes were respectively transplanted under the kidney capsule of NOG mice to investigate their differentiation potential in vivo. A eutopic transplantation model was constructed by grafting recellularized uterine matrix loaded up with CM-Dil labeled adventitial cells or pericytes into the injury region of nude rat's uterus.
CD34+ adventitial cells were mainly located at the outmost layer of endometrial large vessels, while CD146+ pericytes were found surrounding the inner endothelial cells of microvessels. A small proportion of CD34+ adventitial cells expressed SUSD2. The number of adventitial cells was ∼40 times higher than that of pericytes in the endometrium. Both adventitial cells and pericytes showed MSC phenotypes after in vitro culture. After in vitro induction into endometrial endothelial-like cells and stromal-like cells, adventitial cells showed higher plasticity than pericytes and a closer correlation with stromal-like cells. In the mouse xenotransplantation model, vimentin+ cells, CD31+ endothelial-like cells and CD146+ pericyte-like cells could be observed after adventitial cells were transplanted. CM-Dil-labeled adventitial cells or pericytes could survive in the immunocompromised nude rats after eutopic transplantation, and vimentin+ cells were detected. In addition, CM-Dil-labeled adventitial cells or pericytes did not express α-smooth muscle actin or E-cadherin after transplantation.
N/A.
LIMITATIONS, REASONS FOR CAUTION: CD34 was chosen as a novel marker to isolate adventitial cells from human endometrium according to previous literature. The association of endometrial CD34+ adventitial cells and SUSD2+ MSCs should be further investigated.
The decellularized uterine matrix model might be useful in endometrial stem cell therapy.
STUDY FUNDING/COMPETING INTEREST(S): L.D. is supported by grants from National Key Research and Development Program of China (2018YFC1004700), Nature Science Foundation of China (81871128, 81571391) and Nanjing Medical Science Development Project (ZKX16042). H.S. is supported by a grant from Jiangsu Province Social Development Project (BE2018602). X.Z. was supported by grants from the Postgraduate Innovative Project of Jiangsu Province (KYCX19-1177). The authors declare no conflict of interest.
在人类子宫内膜中,两种血管周干细胞,即 CD34+ 血管周细胞和 CD146+ 周细胞,其定位、特征和组织再生潜力如何?
人子宫内膜 CD34+ 血管周细胞(位于血管的最外层,主要位于基底层)和 CD146+ 周细胞在体外培养中表现出间充质干细胞(MSC)表型,但再生子宫内膜的潜力有限。
周期性子宫内膜再生被认为是由 MSC 维持的。血管壁被认为是干细胞龛,它蕴藏着大量的祖细胞,这些祖细胞可能是 MSC 起源的重要组成部分。然而,缺乏经过验证的标记物阻碍了对潜在子宫内膜 MSC 的分离。目前,在子宫内膜血管周区域已经鉴定出 CD146+ 周细胞和 Sushi 结构域包含 2(SUSD2)阳性细胞,它们具有 MSC 特征。
研究设计、规模、持续时间:通过免疫荧光染色(n=4)鉴定人子宫内膜中血管周细胞和周细胞的位置。从正常女性子宫内膜中通过荧光激活细胞分选分离出 CD34+CD146-CD45-CD56-CD144-血管周细胞和 CD146+CD34-CD45-CD56-CD144-周细胞(n=6)后,在体外分别诱导其分化为血管内皮样细胞或子宫内膜基质样细胞,通过体内异种移植(每组 n=2)和在位移植(每组 n=2)探索其潜力。
参与者/材料、设置、方法:将 CD34+ 血管周细胞和 CD146+ 周细胞在诱导培养基中培养,体外诱导分化为内皮样细胞,然后分析 CD31、血管性血友病因子免疫荧光染色和管形成。还将它们培养成体外子宫内膜基质细胞,在诱导前后通过 Western blot 检测波形蛋白和 CD13 的表达,并测定催乳素和胰岛素样生长因子结合蛋白 1 的表达。将单独分散的 CD34+ 血管周细胞和 CD146+ 周细胞分别移植到 NOG 小鼠的肾脏包膜下,以研究其在体内的分化潜力。通过将 CM-Dil 标记的血管周细胞或周细胞负载到再细胞化的子宫基质中,构建在位移植模型,并将其移植到裸鼠子宫的损伤区域。
CD34+ 血管周细胞主要位于子宫内膜大血管的最外层,而 CD146+ 周细胞位于微血管的内内皮细胞周围。一小部分 CD34+ 血管周细胞表达 SUSD2。子宫内膜中血管周细胞的数量约为周细胞的 40 倍。血管周细胞和周细胞在体外培养后均表现出 MSC 表型。体外诱导成子宫内膜内皮样细胞和基质样细胞后,血管周细胞的可塑性高于周细胞,与基质样细胞的相关性更高。在小鼠异种移植模型中,移植血管周细胞后可观察到 vimentin+ 细胞、CD31+ 内皮样细胞和 CD146+ 周细胞样细胞。CM-Dil 标记的血管周细胞或周细胞在免疫缺陷裸鼠在位移植后可存活,并检测到 vimentin+ 细胞。此外,移植后 CM-Dil 标记的血管周细胞或周细胞不表达α-平滑肌肌动蛋白或 E-钙黏蛋白。
无。
局限性、谨慎的原因:根据先前的文献,选择 CD34 作为分离人子宫内膜血管周细胞的新型标记物。需要进一步研究子宫内膜 CD34+ 血管周细胞与 SUSD2+MSC 的关系。
去细胞化子宫基质模型可能对子宫内膜干细胞治疗有用。
研究资金/利益冲突:L.D. 得到国家重点研发计划(2018YFC1004700)、国家自然科学基金(81871128、81571391)和南京市医学科技发展项目(ZKX16042)的支持。H.S. 得到江苏省社会发展项目(BE2018602)的支持。X.Z. 得到江苏省研究生创新项目(KYCX19-1177)的支持。作者声明没有利益冲突。